뇌파계/EEG 시스템 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)

Electroencephalography Devices/EEG System Market By Type (EEG Equipment And EEG Accessories), Modality (Portable Device And Non-Portable Device), By Application (Disease Diagnosis, Anaesthesia Monitoring, Sleep Monitoring, And Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of various neurological diseases and the increasing figures of brain injury across the globe

The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030. The demand for EEG devices is primarily being boosted by the increasing figures of neurologic disorders such as epilepsy, stroke, coma, sleeping disorders, and others. Further, the rising adoption of advanced and innovative technologies, the increasing geriatric population, the increasing device launches & approval, and others are contributing to the overall growth of the EEG devices market during the forecast period from 2024-2030.

Electroencephalography Devices/EEG System Market Dynamics:

The EEG device market is witnessing a growth in product demand owing to various factors, one of the key factors being the increase in the prevalence of various neurological diseases such as epilepsy, sclerosis, dementia, and others.

For instance, according to World Health Organization (WHO) 2023, globally, an estimated 5 million people were diagnosed with epilepsy each year. In high-income countries, 49 per 100,000 people are diagnosed with epilepsy each year. In low- and middle-income countries, this figure can be as high as 139 per 100,000 people. Therefore, the increasing cases of epilepsy will need an EEG device to diagnose epilepsy as the device records activity from the cortex and the deeper brain structures. Thus, the increasing number of cases of epilepsy will increase the demand for EEG devices in the forecast year.

Furthermore, a stroke occurs when the blood supply to the brain is reduced which prevents brain tissue from getting oxygen and nutrients. Also, people with lesions in their brains may have unusually slow EEG waves, depending on the size and the location of the lesion. The EEG devices are rapidly sensitive to brain ischemia and immediately detect changes in brain function. For instance, according to World Stroke Organization 2022, there were 12.2 million new strokes per year around the world which is 1 in every 3 seconds. The same source also stated that 1 in 4 people will have a stroke in their lifetime. Thus, the increasing stroke cases will increase the demand for EEG devices as these devices aid in the diagnosis of such neurological diseases. Therefore, the above-mentioned factors are contributing to the growth of the EEG device market during the forecast period from 2024-2030.

However, the limitation related to EEG devices, the presence of alternative devices, and others may restrict the EEG device market growth.

Electroencephalography Devices/EEG System Market Segment Analysis:

EEG Device Market by Type (EEG Equipment and EEG Accessories), Modality (Portable Device and Non-Portable Device), Application (Disease Diagnosis, Anesthesia Monitoring, Sleep Monitoring, and Others), End-User (Hospitals, Home Healthcare, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the modality segment of the EEG System market, the portable devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages offered by the segment.

For instance, after any injury or disease, patients need continuous monitoring of the brain and its activity. In such cases, portable EEG devices are advised to measure the physiological condition of the brain.

Further, the increasing cases of traumatic brain injury, product launches, approval, mergers, and others will increase the demand for portable EEG devices. For instance, according to Academy for Multidisciplinary Neurotraumatology (AMN) 2022, it is considered that somewhere around 64 to 74 million new cases of Traumatic brain injury (TBI) occur annually worldwide, in conclusion, 69 million people worldwide suffer a TBI each year. After the brain injury, a person needs continuous monitoring of the brain either in hospital or after hospital discharge, to observe any changes in the brain activity. In such cases, continuous and portable EEG monitoring may help in early neurological prognostication, to detect abnormalities at a reversible stage, to access the benefits of interventions, and to prevent neurological complications. Thus, the increasing number of cases of TBI worldwide will increase the demand for EEG devices during the forecast period.

The increasing product launches and approval for portable EEG devices will also create a positive impact on the demand of this segment. For instance, in January 2023, Compumedics Limited received FDA approval for the OKTI system. The Okti System is intended for use in the diagnosis of various neurological disorders, a deep understanding of patient care, and also be used for routine and long Term EEG. The Okti is a simple, portable, wireless system. The wireless capability gives physicians the option of monitoring a patient's physiological data while the patients are out of bed, helping to ensure they capture critical clinical events on the recording.

Therefore, owing to the advantages offered by portable devices will increase the demand for portable EEG devices thereby, driving the growth of the EEG device market during the forecast period.

North America is expected to dominate the overall Electroencephalography Devices/EEG System Market:

Among all the regions, North America is estimated to account for the largest share of the EEG device market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing cases of road accidents, and others are driving the North America EEG device market. Furthermore, the increasing geriatric population, high disposable income, sophisticated healthcare infrastructure, and regulatory approval for new devices will also help in the market growth in this region.

The aging population creates an increase in health-related issues, especially in neurological diseases due to the physiological changes that can cause glitches in brain functions, as the hormones and proteins decline with age. Older people often experience decreased blood flow to the brain, which can impair memory and can lead to changes in cognitive skills. Therefore, to prevent any future complications older people need continuous monitoring of the brain, which can be provided by an EEG device. For instance, according to the Centers for Disease and Prevention Control (CDC) 2022, by 2040, the number of older adults in the United States is expected to reach 80.8 million. By 2060, it will reach 94.7 million, and older adults will make up nearly 25% of the US population. Thus, the increasing geriatric population in the US will increase the demand for EEG devices as elderly patients may need to use EEG devices for continued monitoring of the brain's activity which can help to diagnose any chronic changes in the brain and to prevent stroke or other life-threatening conditions. Thus, the increasing geriatric population in North America will increase the demand for EEG devices during the forecast period.

Further, in sleep apnea the extracted signals from EEG allow a person to monitor brain activities and diagnose sleep disorders such as insomnia, narcolepsy-cataplexy syndrome, and obstructive sleep apnoea syndrome. For instance, as per the CDC 2022, in 2020, 14.5% of adults had trouble falling asleep most days or every day in the past 30 days in the US. As per the same source, a greater percentage of non-Hispanic White (21.0%) adults had trouble staying asleep most days or every day compared with non-Hispanic Black (15.4%), Hispanic (10.6%), and non-Hispanic Asian (8.7%) adults. Younger adults were less likely to have trouble staying asleep (13.8%) of those aged 18-44) compared with adults aged 45-64 (21.8%). Thus, the increasing population of sleep apnea will increase the demand for EEG devices as these devices are used for continuous monitoring of brain activity and sleeping obstruction.

Coupled with the factors mentioned above, strategic activities such as product launches & approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in August 20221 Ceribell, Inc. received FDA approval for Ceribell Instant EEG Headband. The Ceribell Instant EEG Headband is an electroencephalogram (EEG) electrode array intended for single-patient use, it records EEG in patients of 2 years and older. The instant EEG headband is intended for prescription use in the home, healthcare facility, or clinical research environment. Thus, such strategic steps help to increase the demand for EEG devices, thereby driving the North America EEG device market forward during the forecast period.

Electroencephalography Devices/EEG System Market Key Players:

Some of the key market players operating in the EEG devices market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.

Recent Developmental Activities in the Electroencephalography Devices/EEG System Market:

In January 2023, Bioserenity received FDA approval for Neuronaute with IceCap 2 & IceCap 2 Small. Neuronaute with IceCap2 & IceCap 2 Small, is a system intended to acquire, display, store, archive, and periodically transmit EEG signals from the brain using a full montage array to enable review at a physician's office, hospital, or other remote locations.

In December 2022, Natus Medical completed the previously announced acquisition with Micromed Holdings. Natus Neuro Team will work closely with Micromed management to build upon the Micromed momentum in the European epilepsy market and the emerging presence of Moberg in the ICU.

In December 2021, WAVi Co. received FDA approval for WAVi SCAN EEG System and Accessories. WAVi SCAN is intended for the acquisition, display, and storage, of electrical activity of a patient's brain including electroencephalograph (EEG) and event-related potentials (ERP) obtained by placing two or more electrodes on the head to aid in diagnosis.

In July 2021, Seer medical pty ltd. received FDA approval for Seer Home EEG device. The EEG system Seer Home is intended to acquire, display, and store the electro-physiological signals of the patient's brain obtained by placing electrodes on the patient's scalp.

Key Takeaways from the Electroencephalography Devices/EEG System Market Report Study

Market size analysis for current EEG device market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the EEG device market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global EEG device market.

Various opportunities available for the other competitor in the EEG device market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current EEG device market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for EEG device market growth in the coming future?

Target Audience who can be benefited from this Electroencephalography Devices/Eeg System Market Report Study

EEG device products providers

Research organizations and consulting companies

EEG device-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in EEG device

Various End-users who want to know more about the EEG device market and the latest technological developments in the EEG device market.

Frequently Asked Questions For the Electroencephalography Devices/Eeg System Market:

1. What are electroencephalography devices/EEG systems?

Electroencephalography (EEG) devices, is a medical device that detects abnormalities in brain waves, or the electrical activity in the brain that might be useful in diagnosing various brain disorders, such as epilepsy or seizure.

The device can also help diagnose dementia, sleep disorder, Alzheimer's disease, brain tumors, encephalitis, and others.

2. What is the market for global electroencephalography devices/EEG systems?

The global electroencephalography devices or EEG system market was valued at USD 1,050.48 million in 2023, growing at a CAGR of 9.96% during the forecast period from 2024 to 2030 to reach USD 1,850.84 million by 2030.

3. What are the drivers for the global electroencephalography devices/EEG system market?

The demand for EEG devices is primarily being heightened by the increasing prevalence of neurological diseases such as epilepsy, stroke, Alzheimer's disease, and others. In addition, the advancement in EEG devices, the increasing number of traumatic brain injuries, the rising geriatric population prone to neurological disorders, the increasing device launches & approvals, and others contribute to the overall growth of the EEG device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global electroencephalography devices/EEG system market?

Some of the key market players operating in the EEG device market include Allengers, Nihon kohden corporation, cadwell industries, magstim EGI, Masimo, Natus Medical Incorporated, NeuroWave System Inc., Seer Medical, Cerbell, Inc., Koninklijke Philips N.V., Compumedics, NeuroSky, Lifelines Neuro, Neurosoft, BrainScope Company Inc, Advanced Brain Monitoring, Inc, EB Neuro S.p.A., g.tec medical engineering GmbH Austria, Bitbrain Technologies, WAVi, and others.

5. Which region has the highest share in the electroencephalography devices/EEG system market?

North America is expected to dominate the overall EEG device market during the forecast period from 2024-2030. Factors such as the rising prevalence of sleep disorders, the growing cases of Alzheimer's disease, the increasing geriatric population, and others will create a positive impact on the North America EEG market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and increasing awareness about regular monitoring of brain activity will also help in the market growth in this region.

Table of Contents

1.Electroencephalography Devices/EEG System Market Report Introduction

2. Electroencephalography Devices/EEG System Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Electroencephalography Devices/EEG System Market Key Factors Analysis

• 4.1. Electroencephalography Devices/EEG System Market Drivers
  • 4.1.1. Rising prevalence of neurological disorders
  • 4.1.2. Increasing figure of brain injury
  • 4.1.3. Technological advancement in the field of EEG equipment and increasing investment in R&D
• 4.2. Electroencephalography Devices/EEG System Market Restraints and Challenges
  • 4.2.1. Limitations of EEG devices
  • 4.2.2. Presence of alternative devices
• 4.3. Electroencephalography Devices/EEG System Market Opportunities
  • 4.3.1. Growing digitalization in EEG devices
  • 4.3.2. Increasing demand for wearable EEG devices

5. Electroencephalography Devices/EEG System Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Electroencephalography Devices/EEG System Market Layout

• 6.1. By Type
  • 6.1.1. EEG equipment
  • 6.1.2. EEG accessories
• 6.2. By Modality
  • 6.2.1. Portable Device
  • 6.2.2. Non-Portable Device
• 6.3. By Application
  • 6.3.1. Disease Diagnosis
  • 6.3.2. Anesthesia Monitoring
  • 6.3.3. Sleep Monitoring
  • 6.3.4. Others
• 6.4. By End-User
  • 6.4.1. Hospitals
  • 6.4.2. Home Healthcare
  • 6.4.3. Diagnostic Centers
  • 6.4.4. Others
• 6.5. By Geography
  • 6.5.1. North America
    • 6.5.1.1. United States Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.1.2. Canada Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.1.3. Mexico Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
  • 6.5.2. Europe
    • 6.5.2.1. France Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2.2. Germany Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2.3. United Kingdom Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2.4. Italy Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2.5. Spain Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.2.6. Rest of Europe Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
  • 6.5.3. Asia-Pacific
    • 6.5.3.1. China Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3.2. Japan Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3.3. India Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3.4. Australia Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3.5. South Korea Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.3.6. Rest of Asia-Pacific Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
  • 6.5.4. Rest of the World (RoW)
    • 6.5.4.1. Middle East Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.4.2. Africa Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)
    • 6.5.4.3. South America Electroencephalography Devices/EEG System Market Size in USD million (2021-2030)

7. Electroencephalography Devices/EEG System Market Company and Product Profiles

• 7.1. Allengers
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. NIHON KOHDEN CORPORATION
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Cadwell Industries Inc.
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Magstim EGI
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Masimo.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Natus Medical Incorporated
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. NeuroWave Systems Inc.
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Seer Medical
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Ceribell, Inc.
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Koninklijke Philips N.V.
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. Compumedics
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. NeuroSky
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. Lifelines Neuro
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. Neurosoft
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. BrainScope Company Inc
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy
• 7.16. Advanced Brain Monitoring, Inc.
  • 7.16.1. Company Overview
  • 7.16.2. Company Snapshot
  • 7.16.3. Financial Overview
  • 7.16.4. Product Listing
  • 7.16.5. Entropy
• 7.17. EB Neuro S.p.A.
  • 7.17.1. Company Overview
  • 7.17.2. Company Snapshot
  • 7.17.3. Financial Overview
  • 7.17.4. Product Listing
  • 7.17.5. Entropy
• 7.18. g.tec medical engineering GmbH Austria
  • 7.18.1. Company Overview
  • 7.18.2. Company Snapshot
  • 7.18.3. Financial Overview
  • 7.18.4. Product Listing
  • 7.18.5. Entropy
• 7.19. Bitbrain Technologies
  • 7.19.1. Company Overview
  • 7.19.2. Company Snapshot
  • 7.19.3. Financial Overview
  • 7.19.4. Product Listing
  • 7.19.5. Entropy
• 7.20. WAVi
  • 7.20.1. Company Overview
  • 7.20.2. Company Snapshot
  • 7.20.3. Financial Overview
  • 7.20.4. Product Listing
  • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us